These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3450927)

  • 21. Cell DNA content--correlation with clonogenicity in the human tumour cloning system (HTCS).
    Verheijen RH; Feitz WF; Beck JL; Debruyne FM; Vooys GP; Kenemans P; Herman CJ
    Int J Cancer; 1985 May; 35(5):653-7. PubMed ID: 3997285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An in vitro chemosensitivity study using human tumor clonogenic assay in urologic malignancies].
    Naito K; Hisazumi H; Asari T; Kobashi K; Amano T; Uchibayashi T
    Hinyokika Kiyo; 1986 Dec; 32(12):1959-66. PubMed ID: 3825833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonogenic assay for urologic malignancies.
    Hashimura T; Tanigawa N; Okada K; Yoshida O
    Gan; 1984 Aug; 75(8):724-8. PubMed ID: 6489680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole.
    Howell SB; Hom D; Sanga R; Vick JS; Abramson IS
    Cancer Res; 1989 Jun; 49(12):3178-83. PubMed ID: 2720673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX; Ogawa O; Kakehi Y
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling.
    Takano Y; Iwata H; Yano Y; Miyazawa M; Virgona N; Sato H; Ueno K; Yano T
    Biochem Pharmacol; 2010 Aug; 80(4):463-70. PubMed ID: 20510207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro antiproliferative effect of cancer chemotherapeutic agents and their combination with interferon in renal cell carcinoma].
    Tsukamoto T; Kumamoto Y; Miyao N; Omura K; Yamazaki K
    Nihon Hinyokika Gakkai Zasshi; 1989 Jan; 80(1):88-94. PubMed ID: 2724750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new interferon-alpha assay system including indirect antitumor effect. Basic and clinical study of renal cell carcinoma].
    Yoshihiro S
    Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):338-47. PubMed ID: 1564836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enhancement of cytotoxicity of anticancer drugs by verapamil--effects on established human renal tumor cell line].
    Watanabe Y
    Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):11-9. PubMed ID: 3398369
    [No Abstract]   [Full Text] [Related]  

  • 30. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Circumvention of the intrinsic multidrug-resistance in renal cell carcinoma].
    Kakehi Y; Segawa T; Hashimura T; Yoshida O
    Hinyokika Kiyo; 1992 Nov; 38(11):1319-24. PubMed ID: 1485588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.
    Long QZ; Zhou M; Liu XG; Du YF; Fan JH; Li X; He DL
    Anticancer Drugs; 2013 Sep; 24(8):810-7. PubMed ID: 23744557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro chemosensitivity test for testicular cancer using a human tumor stem cell assay].
    Yamamoto N; Matsuyama H; Shinohara Y; Shimizu K; Sakatoku J
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2229-35. PubMed ID: 2420907
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal cell carcinoma and the clonogenic assay.
    Fleischmann J; Heston WD; Fair WR
    J Urol; 1983 Dec; 130(6):1060-2. PubMed ID: 6644882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
    Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human renal cell carcinoma: establishment of a new cell line (YCR-1) using soft agar culture technic].
    Masuda M; Sakuramoto T; Moriyama M; Miura T; Shuin T; Kubota Y
    Nihon Hinyokika Gakkai Zasshi; 1986 Apr; 77(4):653-8. PubMed ID: 3528602
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay.
    Welander CE; Morgan TM; Homesley HD; Trotta PP; Spiegel RJ
    Int J Cancer; 1985 Jun; 35(6):721-9. PubMed ID: 4008100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data.
    Debruyne FM; Franssen MP; Beniers AJ; Schalken JA; de Mulder PH
    Prog Clin Biol Res; 1990; 350():243-55. PubMed ID: 2117284
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma.
    Tannock IF; Evans WK
    Cancer Treat Rep; 1985 Feb; 69(2):227-8. PubMed ID: 3882231
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytogenetic analysis of urologic malignancies: study of tumor colony forming cells and premature chromosome condensation.
    Trent JM; Stanisic T; Olson S
    J Urol; 1984 Jan; 131(1):146-51. PubMed ID: 6690740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.